PTC1 Mutant (CCDC6-RET), Active from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
PTC1 Mutant (CCDC6-RET), Active

Get Pricing

Description

Description: Recombinant human RET/PTC1, the fusion protein [CCDC6 (1-101)-RET (713-end)], was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Scientific Background: RET/PTC1 is fused of RET and the activating CCDC6 gene by intrachromosomal paracentric inversions in chromo-some 10 (1). Likes RET/PTC3, it is the most frequent RET rearrangements in papillary thyroid carcinoma (PTC) (2), especially in radiation-induced tumours. The RET/PTC1 rearrangements may be a marker for later-occurring PTC of radiation-exposed children and adults (3). The RET/PTC rearrangements also have been shown in benign thyroid lesions, including Hashimoto's thyroiditis (HT)